These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2617837)
21. FDA launches campaign on OTC pain relief products. FDA Consum; 2004; 38(2):8. PubMed ID: 15101357 [TBL] [Abstract][Full Text] [Related]
22. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting. Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553 [TBL] [Abstract][Full Text] [Related]
23. Stability analysis for drugs with multiple active ingredients. Chow SC; Shao J Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533 [TBL] [Abstract][Full Text] [Related]
24. Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS. Fed Regist; 1999 Mar; 64(51):13066-7. PubMed ID: 10557605 [TBL] [Abstract][Full Text] [Related]
25. The FDA warns of the dangers of ephedrine. Chase SL RN; 1996 Dec; 59(12):67. PubMed ID: 9001077 [No Abstract] [Full Text] [Related]
26. Child-resistant packaging for certain over-the-counter drug products. Final rule. Consumer Product Safety Commission Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555 [TBL] [Abstract][Full Text] [Related]
27. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
28. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971 [TBL] [Abstract][Full Text] [Related]
29. Regarding "phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project". Clapp R; Williams ML Ann Epidemiol; 2006 Jul; 16(7):580-2; author reply 586. PubMed ID: 16814149 [No Abstract] [Full Text] [Related]
30. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule. Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740 [TBL] [Abstract][Full Text] [Related]
31. Bad news for dieters: a focus on ephedrine. Riffel K Kans Nurse; 2003 Apr; 78(4):6-9. PubMed ID: 12769034 [No Abstract] [Full Text] [Related]
32. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 May; 67(90):31125-7. PubMed ID: 12001972 [TBL] [Abstract][Full Text] [Related]
33. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule. Food and Drug Administration, HHS Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351 [TBL] [Abstract][Full Text] [Related]
34. Trimming down: the debate over weight loss drugs and the push for a leaner FDA, 1979-2001. Richert L Pharm Hist; 2011; 53(2-3):55-69. PubMed ID: 23045876 [No Abstract] [Full Text] [Related]
35. Getting your vitamins and minerals through diet. The benefits of multivitamins are looking doubtful. Can we do without them? Harv Womens Health Watch; 2009 Jul; 16(11):1-3. PubMed ID: 19777673 [No Abstract] [Full Text] [Related]
36. Over-the-counter medications: Zicam nasal products may cause loss of sense of smell.. Child Health Alert; 2009 Sep; 27():3. PubMed ID: 19802908 [No Abstract] [Full Text] [Related]
37. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
38. Theophylline is off the OTC market. Ephedrine may be next. Chase SL RN; 1995 Dec; 58(12):79. PubMed ID: 8560184 [No Abstract] [Full Text] [Related]
39. Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule. Fed Regist; 1998 Nov; 63(213):59463-71. PubMed ID: 10187120 [TBL] [Abstract][Full Text] [Related]
40. FDA advisers vote against OTC Pravachol. Walczak IM Diabetes Technol Ther; 2000; 2(3):483-4. PubMed ID: 11467352 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]